Page 496 - Multidisipliner Covid 19

BÖLÜM 27

57. Pereira MR, Mohan S, Cohen DJ, et al. COVID-19 in solid organ trans-
plant recipients: Initial report from the US epicenter. Am J Transplant.
2020:10.1111/ajt.15941.
58. Fernández-Ruiz M, Andrés A, Loinaz C, et al. COVID-19 in solid organ
transplant recipients: A single-center case series from Spain. Am J
Transplant. 2020 Apr 16.
59. Banerjee D, Popoola J, Shah S, Ster IC, Quan V, Phanish M. COVID-
19 infection in kidney transplant recipients. Kidney Int. 2020;97(6):1076-
82.
60. Lubetzky M, Aull M, Craig-Shapiro R, et al. Kidney allograft recipients
diagnosed with coronavirus disease-2019: A single center report. [eri-
şim 12 Haziran 2020].https://www.medrxiv.org/content/10.1101/
2020.04.30.20086462v2.
61. Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively
inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.
Cell Res. 2020;30(3):269-71.
62. Husain SA, Dube G, Morris H, et al. Early outcomes of outpatient
management of kidney transplant recipients with coronavirus disease
2019. Clin J Am Soc Nephrol. 2020:CJN.05170420.
63. Limaye AP. Coronavirus disease 2019 (COVID-19): Issues related to
solid organ transplantation. 2020 UpToDate. [erişim 12 Haziran 2020].
https://www.uptodate.com/contents/coronavirus-disease-2019-cov-
id-19-issues-related-to-solid-organ-transplantation?topicRef=127552
&source=related_link#H984275705.
64. Conti P, Ronconi G, Caraffa A, et al. Induction of pro-inflammatory
cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19
(COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul
Homeost Agents. 2020;34(2):1.
65. Willicombe M, Thomas D, McAdoo S. COVID-19 and calcineurin in-
hibitors: Should they get left out in the storm? J Am Soc Nephrol.
2020;31(6):1145-6.
66. Maggiore U, Abramowicz D, Crespo M, et al. How should I manage
immunosuppression in a kidney transplant patient with COVID-19?
An ERA-EDTA DESCARTES expert opinion. Nephrol Dial Transplant.
2020;35(6):899-904.
67. Perico L, Benigni A, Remuzzi G. Should COVID-19 concern nephrolo-
gists? Why and to what extent? The emerging impasse of angiotensin

495